Physician profile
Steven Kurtzman
NPI 1114918851
$832,849.05
in general payments reported to CMS, 2019-2025
14 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222K · 2020: $220K · 2021: $221K · 2022: $167K · 2023: $596 · 2024: $1,449 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,885 · Travel and Lodging: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,884.81 |
| Travel and Lodging | $370.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Isoray, INC | $827,416.48 | 2019-2023 | Brachytherapy Source |
| Boston Scientific Corporation | $2,131.50 | 2019-2024 | Spaceoar Vue System - 10ml, Spaceoar System, Rezum Generator |
| Theragenics Corporation | $1,304.90 | 2022-2024 | |
| Palette Life Sciences, INC. | $1,143.63 | 2021-2023 | |
| Teleflex LLC | $190.78 | 2025 | Barrigel |
| Bioprotect Medical, INC. | $187.15 | 2024 | Bioprotect Balloon Implant System |
| Gt Medical Technologies, INC | $131.77 | 2019-2021 | |
| Amgen INC. | $115.76 | 2020 | |
| Varian Medical Systems, INC. | $63.46 | 2021 | |
| Qfix | $58.46 | 2021 | |
| Abbvie INC. | $41.78 | 2024 | |
| Siemens Medical Solutions USA, INC. | $22.24 | 2024 | Bravos Afterloader System |
| Telix Pharmaceuticals | $22.13 | 2024 | Illuccix |
| Tolmar, INC. | $19.01 | 2025 | Eligard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kurtzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.